Abivax S.a.
Clinical trials sponsored by Abivax S.a., explained in plain language.
-
New hope for Crohn's? experimental drug obefazimod enters Mid-Stage trial
Disease control Recruiting nowThis study tests whether obefazimod can reduce symptoms and gut inflammation in people with moderate-to-severe Crohn's disease who haven't responded well to other treatments. About 212 adults will receive either the drug or a placebo for up to 92 weeks. The goal is to see if the …
Phase: PHASE2 • Sponsor: Abivax S.A. • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC
-
Healthy volunteers Taste-Test new mini pill for future Kids' medicine
Knowledge-focused Recruiting nowThis study is testing a new, smaller minitablet version of the drug obefazimod in 44 healthy adults aged 18 to 55. The goal is to see how well the body absorbs the minitablet compared to the current capsule and whether the minitablet tastes acceptable. This is an early-stage stud…
Phase: PHASE1 • Sponsor: Abivax S.A. • Aim: Knowledge-focused
Last updated May 16, 2026 23:37 UTC